Shares of Indian pharma companies gain on defensive buying

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Shares of Indian pharmaceutical companies perceived as defensive gain on risk aversion after overseas investors sold Rs 267 crore worth of Indian shares on Friday, extending their selling streak to a seventh day, provisional exchange data shows, dealers say.

"Stable cash flows and lower volatility of Indian pharma stocks are leading to some flows in the sector ahead of key events like Yellen's speech and inflation data," a dealer said.

Sun Pharmaceutical Industries gains 1.8 percent, Dr.Reddy's Laboratories is up 1.9 percent and Cipla Ltd is higher 1.2 percent.

Caution is also seen ahead of consumer price inflation and industrial output data due later in the week.